Loading clinical trials...
Loading clinical trials...
The purpose of this study is to find out if giving oral HYCAMTIN to patients with relapsed small cell lung cancer benefits them. The study will compare how long patients live when they are given thera...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
GlaxoSmithKline
NCT07219251 · Lung Cancer (NSCLC), Lung Adenocarcinoma, and more
NCT06293833 · Lung Cancer, Nonsmall Cell, Lung Cancer, and more
NCT03499678 · Lung Cancer, Lung Cancer, Nonsmall Cell, and more
NCT05228496 · Lung Cancer, Small Cell
NCT05320458 · Lung Cancer, Lung Cancer, Small Cell
GSK Investigational Site
Pleven
GSK Investigational Site
Plovdiv
GSK Investigational Site
Varna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions